Dorothy Park

910 total citations · 1 hit paper
8 papers, 805 citations indexed

About

Dorothy Park is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dorothy Park has authored 8 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dorothy Park's work include Viral-associated cancers and disorders (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Histiocytic Disorders and Treatments (2 papers). Dorothy Park is often cited by papers focused on Viral-associated cancers and disorders (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Histiocytic Disorders and Treatments (2 papers). Dorothy Park collaborates with scholars based in United States and Japan. Dorothy Park's co-authors include H. Phillip Koeffler, Jonathan Said, Elizabeth A. Williamson, Hiroya Asou, Peter Shintaku, Elena Elstner, David Heber, Carsten Müller‐Tidow, Kozo Koshizuka and Jun Yokota and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Dorothy Park

8 papers receiving 795 citations

Hit Papers

Ligands for peroxisome proliferator-activated receptorγ a... 1998 2026 2007 2016 1998 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorothy Park United States 5 658 353 178 177 77 8 805
Christopher Fletcher United Kingdom 3 656 1.0× 349 1.0× 167 0.9× 123 0.7× 77 1.0× 4 746
Sharada Katkuri United States 7 592 0.9× 364 1.0× 490 2.8× 212 1.2× 185 2.4× 7 1.0k
William Bayona United States 7 653 1.0× 179 0.5× 148 0.8× 245 1.4× 84 1.1× 7 922
Rut Porta Spain 9 289 0.4× 163 0.5× 121 0.7× 114 0.6× 50 0.6× 17 527
José Luís Oliva Spain 15 425 0.6× 95 0.3× 58 0.3× 101 0.6× 29 0.4× 23 596
Rajesh Bazaz United States 11 258 0.4× 139 0.4× 143 0.8× 78 0.4× 64 0.8× 13 549
Yoshiki Amuro Japan 17 341 0.5× 87 0.2× 104 0.6× 222 1.3× 51 0.7× 52 735
Dianren Xia United States 10 314 0.5× 120 0.3× 76 0.4× 114 0.6× 59 0.8× 17 487
Lynn N. Thomas Canada 18 424 0.6× 212 0.6× 38 0.2× 75 0.4× 170 2.2× 31 1.3k
J.K. Mellon United Kingdom 12 380 0.6× 216 0.6× 36 0.2× 168 0.9× 42 0.5× 20 731

Countries citing papers authored by Dorothy Park

Since Specialization
Citations

This map shows the geographic impact of Dorothy Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothy Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothy Park more than expected).

Fields of papers citing papers by Dorothy Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothy Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothy Park. The network helps show where Dorothy Park may publish in the future.

Co-authorship network of co-authors of Dorothy Park

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothy Park. A scholar is included among the top collaborators of Dorothy Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothy Park. Dorothy Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
McArthur, Heather L., Stephen L. Shiao, Scott Karlan, et al.. (2021). Abstract PS12-09: Pre-operative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). Cancer Research. 81(4_Supplement). PS12–9. 5 indexed citations
2.
McArthur, Heather L., Stephen L. Shiao, Scott Karlan, et al.. (2020). Abstract P3-09-09: Pre-operative pembrolizumab (pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). Cancer Research. 80(4_Supplement). P3–9. 3 indexed citations
3.
Waqar, Saiama N., Sant P. Chawla, Dorothy Park, et al.. (2017). P2.03a-003 Belinostat in Combination with Carboplatin and Paclitaxel in Patients with Chemotherapy-Naive Metastatic Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S888–S889. 3 indexed citations
4.
Elstner, Elena, Carsten Müller‐Tidow, Kozo Koshizuka, et al.. (1998). Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proceedings of the National Academy of Sciences. 95(15). 8806–8811. 719 indexed citations breakdown →
5.
Munker, Reinhold, Taizo Tasaka, Dorothy Park, Carl W. Miller, & H. Phillip Koeffler. (1997). HHV-8 (KSHV) does not establish latency in prostate cancer cell lines. The Prostate. 33(4). 286–288. 8 indexed citations
6.
Tasaka, Taizo, Jonathan Said, Roberta Morosetti, et al.. (1997). Is Kaposi's Sarcoma–Associated Herpesvirus Ubiquitous in Urogenital and Prostate Tissues?. Blood. 89(5). 1686–1689. 2 indexed citations
7.
Tasaka, Taizo, Jonathan Said, Roberta Morosetti, et al.. (1997). Is Kaposi's Sarcoma–Associated Herpesvirus Ubiquitous in Urogenital and Prostate Tissues?. Blood. 89(5). 1686–1689. 33 indexed citations
8.
Kawamata, Norihiko, Dorothy Park, Sharon P. Wilczynski, Jun Yokota, & H. Phillip Koeffler. (1996). Point Mutations of the Mxil Gene are Rare in Prostate Cancers. The Prostate. 29(3). 191–193. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026